Curcuma longa extract associated with white pepper lessens high fat diet-induced inflammation in subcutaneous adipose tissue

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Neyrinck, Audrey M ^a   Alligier, Maud ^a   Memvanga, Patrick B ^a   Névraumont, Elodie ^a   Larondelle, Yvan ^a   Préat, Véronique ^a   Cani, Patrice D ^a   Delzenne, Nathalie M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; CYTOKINE; FAT INTAKE; GLUCOSE BLOOD LEVEL; INSULIN; PLANT EXTRACT; TETRAHYDROCURCUMIN; TURMERIC EXTRACT;

ADMINISTRATION AND DOSAGE; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BLACK PEPPER; BLOOD; C57BL MOUSE; CELL MOTION; CHEMICALLY INDUCED; CHEMISTRY; CURCUMA; DIET SUPPLEMENTATION; DIET THERAPY; DRUG EFFECTS; FAT INTAKE; GLUCOSE BLOOD LEVEL; INFLAMMATION; LEUKOCYTE; LIPID DIET; MALE; METABOLISM; MICROFLORA; MOUSE; OBESITY; PATHOLOGY; SUBCUTANEOUS FAT; WEIGHT GAIN;

ANIMALS; BLACK PEPPER; BLOOD GLUCOSE; CELL MOVEMENT; CURCUMA; CURCUMIN; CYTOKINES; DIET, HIGH-FAT; DIETARY FATS; DIETARY SUPPLEMENTS; INFLAMMATION; INSULIN; LEUKOCYTES; MALE; MICE; MICE, INBRED C57BL; MICROBIOTA; OBESITY; PLANT EXTRACTS; SUBCUTANEOUS FAT; WEIGHT GAIN;

EID: 84894224317     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081252     Document Type: Article

References (47)

1. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK et al. (2011) National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 377: 557-567. doi:10.1016/S0140-6736(10)62037-5. PubMed: 21295846.
2. Osborn O, Olefsky JM (2012) The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 18: 363-374. doi:10.1038/nm.2627. PubMed: 22395709.
3. Tremaroli V, Bäckhed F (2012) Functional interactions between the gut microbiota and host metabolism. Nature 489: 242-249. doi:10.1038/ nature11552. PubMed: 22972297.
4. Ley RE (2010) Obesity and the human microbiome. Curr Opin Gastroenterol 26: 5-11. doi:10.1097/MOG.0b013e328333d751. PubMed: 19901833.
5. Caesar R, Fåk F, Bäckhed F (2010) Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. J Intern Med 268: 320-328. doi:10.1111/j.1365-2796.2010.02270.x. PubMed: 21050286.
6. Diamant M, Blaak EE, de Vos WM (2011) Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Obes Rev 12: 272-281. PubMed: 20804522.
7. Delzenne NM, Neyrinck AM, Bäckhed F, Cani PD (2011) Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 7: 639-646. doi:10.1038/nrendo.2011.126. PubMed: 21826100.
8. Delzenne NM, Neyrinck AM, Cani PD (2013) Gut microbiota and metabolic disorders: How prebiotic can work? Br J Nutr 109 Suppl 2: S81-S85. doi:10.1017/S0007114512004047. PubMed: 23360884.
9. Delzenne NM, Neyrinck AM, Cani PD (2011) Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Fact 10 Suppl 1: S10. doi:10.1186/1475-2859-10-S1-S10. PubMed: 21995448.
10. Delzenne NM, Cani PD (2011) Interaction between obesity and the gut microbiota: relevance in nutrition. Annu Rev Nutr 31: 15-31. doi:10.1146/annurev-nutr-072610-145146. PubMed: 21568707.
11. Sharma RA, Gescher AJ, Steward WP (2005) Curcumin: the story so far. Eur J Cancer 41: 1955-1968. doi:10.1016/j.ejca.2005.05.009. PubMed: 16081279. (Pubitemid 41557681)
12. Alappat L, Awad AB (2010) Curcumin and obesity: evidence and mechanisms. Nutr Rev 68: 729-738. doi:10.1111/j.1753-4887.2010.00341.x. PubMed: 21091916.
13. Shehzad A, Ha T, Subhan F, Lee YS (2011) New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. Eur J Nutr 50: 151-161. doi:10.1007/s00394-011-0188-1. PubMed: 21442412.
14. Weisberg SP, Leibel R, Tortoriello DV (2008) Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology 149: 3549-3558. doi:10.1210/en.2008-0262. PubMed: 18403477. (Pubitemid 351919581)
15. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4: 807-818. doi:10.1021/mp700113r. PubMed: 17999464.
16. Aggarwal BB (2010) Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu Rev Nutr 30: 173-199. doi:10.1146/annurev.nutr.012809.104755. PubMed: 20420526.
17. Woo HM, Kang JH, Kawada T, Yoo H, Sung MK et al. (2007) Active spice-derived components can inhibit inflammatory responses of adipose tissue in obesity by suppressing inflammatory actions of macrophages and release of monocyte chemoattractant protein-1 from adipocytes. Life Sci 80: 926-931. doi:10.1016/j.lfs.2006.11.030. PubMed: 17196622. (Pubitemid 46186427)
18. Gonzales AM, Orlando RA (2008) Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes. Nutr Metab (Lond) 5: 17. doi:10.1186/1743-7075-5-17. PubMed: 18549505.
19. Oner-İyidoǧan Y, Koçak H, Seyidhanoǧlu M, Gürdöl F, Gülçubuk A et al. (2013) Curcumin prevents liver fat accumulation and serum fetuin-A increase in rats fed a high-fat diet. J Physiol Biochem, 69: 677-86. PubMed: 23430567.
20. El-Moselhy MA, Taye A, Sharkawi SS, El-Sisi SF, Ahmed AF (2011) The antihyperglycemic effect of curcumin in high fat diet fed rats. Role of TNF-alpha and free fatty acids. Food Chem Toxicol 49: 1129-1140. doi:10.1016/j.fct.2011.02.004. PubMed: 21310207.
21. Shao W, Yu Z, Chiang Y, Yang Y, Chai T et al. (2012) Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes. PLOS ONE 7: e28784. doi:10.1371/journal.pone.0028784. PubMed: 22253696.
22. Jang EM, Choi MS, Jung UJ, Kim MJ, Kim HJ et al. (2008) Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat-fed hamsters. Metabolism 57: 1576-1583. doi:10.1016/j.metabol.2008.06.014. PubMed: 18940397.
23. Ejaz A, Wu D, Kwan P, Meydani M (2009) Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J Nutr 139: 919-925. doi:10.3945/jn.108.100966. PubMed: 19297423.
24. Ahn J, Lee H, Kim S, Ha T (2010) Curcumin-induced suppression of adipogenic differentiation is accompanied by activation of Wnt/beta-catenin signaling. Am J Physiol Cell Physiol 298: C1510-C1516. doi:10.1152/ajpheart. 01021.2009. PubMed: 20357182.
25. Sharma RA, Steward WP, Gescher AJ (2007) Pharmacokinetics and pharmacodynamics of curcumin. Adv Exp Med Biol 595: 453-470. doi:10.1007/978-0-387-46401-5-20. PubMed: 17569224.
26. Kemperman RA, Bolca S, Roger LC, Vaughan EE (2010) Novel approaches for analysing gut microbes and dietary polyphenols: challenges and opportunities. Microbiology 156: 3224-3231. doi:10.1099/mic.0.042127-0. PubMed: 20724384.
27. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502. PubMed: 4337382.
28. Neyrinck AM, Possemiers S, Verstraete W, De BF, Cani PD et al. (2012) Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice. J Nutr Biochem 23: 51-59. PubMed: 21411304.
29. Dewulf EM, Cani PD, Neyrinck AM, Possemiers S, Holle AV et al. (2011) Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARgamma-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. J Nutr Biochem 22: 712-722. PubMed: 21115338.
30. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772. doi:10.2337/db06-1491. PubMed: 17456850. (Pubitemid 47025442)
31. Marczylo TH, Steward WP, Gescher AJ (2009) Rapid analysis of curcumin and curcumin metabolites in rat biomatrices using a novel ultraperformance liquid chromatography (UPLC). Methods - J Agric Food Chem 57: 797-803. doi:10.1021/jf803038f.
32. Memvanga PB, Coco R, Préat V (2013) An oral malaria therapy: Curcumin-loaded lipid-based drug delivery systems combined with β-arteether. J Control Release (. (2013)) PubMed: 24021359.
33. Lansky EP, Newman RA (2007) Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol 109: 177-206. doi:10.1016/j.jep.2006.09.006. PubMed: 17157465. (Pubitemid 44959707)
34. Basu A, Penugonda K (2009) Pomegranate juice: a heart-healthy fruit juice. Nutr Rev 67: 49-56. doi:10.1111/j.1753-4887.2008.00133.x. PubMed: 19146506.
35. Aggarwal BB, Shishodia S (2006) Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71: 1397-1421. doi:10.1016/j.bcp.2006.02.009. PubMed: 16563357.
36. Babu PS, Srinivasan K (1997) Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Mol Cell Biochem 166: 169-175. doi:10.1023/A:1006819605211. PubMed: 9046034.
37. Bhandarkar SS, Arbiser JL (2007) Curcumin as an inhibitor of angiogenesis. Adv Exp Med Biol 595: 185-195. doi:10.1007/978-0-387-46401-5-7. PubMed: 17569211.
38. Yoysungnoen P, Wirachwong P, Bhattarakosol P, Niimi H, Patumraj S (2006) Effects of curcumin on tumor angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular carcinoma cell-implanted nude mice. Clin Hemorheol Microcirc 34: 109-115. PubMed: 16543625. (Pubitemid 43351018)
39. Murugan P, Pari L (2006) Effect of tetrahydrocurcumin on plasma antioxidants in streptozotocin-nicotinamide experimental diabetes. J Basic Clin Physiol Pharmacol 17: 231-244. PubMed: 17338279.
40. Murakami Y, Ishii H, Takada N, Tanaka S, Machino M et al. (2008) Comparative anti-inflammatory activities of curcumin and tetrahydrocurcumin based on the phenolic O-H bond dissociation enthalpy, ionization potential and quantum chemical descriptor. Anticancer Res 28: 699-707. PubMed: 18507010. (Pubitemid 351578911)
41. Sandur SK, Pandey MK, Sung B, Ahn KS, Murakami A et al. (2007) Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 28: 1765-1773. doi:10.1093/carcin/bgm123. PubMed: 17522064. (Pubitemid 47289040)
42. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS et al. (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59-65. doi:10.1038/nature08821. PubMed: 20203603.
43. Parkar SG, Stevenson DE, Skinner MA (2008) The potential influence of fruit polyphenols on colonic microflora and human gut health. Int J Food Microbiol 124: 295-298. doi:10.1016/j.ijfoodmicro.2008.03.017. PubMed: 18456359.
44. Tzounis X, Vulevic J, Kuhnle GG, George T, Leonczak J et al. (2008) Flavanol monomer-induced changes to the human faecal microflora. Br J Nutr 99: 782-792. PubMed: 17977475. (Pubitemid 351351632)
45. Selma MV, Espín JC, Tomás-Barberán FA (2009) Interaction between phenolics and gut microbiota: role in human health. J Agric Food Chem 57: 6485-6501. doi:10.1021/jf902107d. PubMed: 19580283.
46. Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG et al. (2007) Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50: 2374-2383. doi:10.1007/s00125-007-0791-0. PubMed: 17823788. (Pubitemid 47512397)
47. Hassaninasab A, Hashimoto Y, Tomita-Yokotani K, Kobayashi M (2011) Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism. Proc Natl Acad Sci U S A 108: 6615-6620. doi:10.1073/pnas.1016217108. PubMed: 21467222.